Synthace Company
Synthace is a Life Sciences R&D cloud platform that enables experiments to be rapidly automated, with the resultant data seamlessly integrated. Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and saleable. Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.
Investors
.png)
.jpeg)
.png)
.png)
.png)
Technology:
Biotechnology, Industrial Automation, Internet of Things, Life Science, Pharmaceutical, Software
Industry:
Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2011-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
16
Total Funding:
80976153
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-11-16
Last Funding Type:
Series C
Register and Claim Ownership